KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Current Assets (2016 - 2025)

Historic Current Assets for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to $737.3 million.

  • Medpace Holdings' Current Assets fell 2859.88% to $737.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $737.3 million, marking a year-over-year decrease of 2859.88%. This contributed to the annual value of $1.0 billion for FY2024, which is 7332.11% up from last year.
  • As of Q3 2025, Medpace Holdings' Current Assets stood at $737.3 million, which was down 2859.88% from $520.8 million recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Current Assets ranged from a high of $1.0 billion in Q3 2024 and a low of $328.9 million during Q2 2022
  • Its 5-year average for Current Assets is $595.8 million, with a median of $550.1 million in 2021.
  • As far as peak fluctuations go, Medpace Holdings' Current Assets plummeted by 5166.36% in 2022, and later soared by 13026.15% in 2024.
  • Medpace Holdings' Current Assets (Quarter) stood at $690.9 million in 2021, then plummeted by 51.66% to $334.0 million in 2022, then skyrocketed by 77.81% to $593.8 million in 2023, then soared by 73.32% to $1.0 billion in 2024, then dropped by 28.37% to $737.3 million in 2025.
  • Its Current Assets stands at $737.3 million for Q3 2025, versus $520.8 million for Q2 2025 and $821.4 million for Q1 2025.